Ingalls & Snyder LLC’s Dynavax Technologies DVAX Stock Holding History

Ingalls & Snyder LLC’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,000	Closed	-$124K	–	443
2024 Q1	$124K	Hold	10,000	–	–	0.01%	424
2023 Q4	$140K	Hold	10,000	–	–	0.01%	410
2023 Q3	$148K	Sell	10,000 -25	-0.2%	-$352	0.01%	399
2023 Q2	$130K	Hold	10,025	–	–	0.01%	409
2023 Q1	$98K	Hold	10,025	–	–	0.01%	406
2022 Q4	$107K	Hold	10,025	–	–	0.01%	416
2022 Q3	$105K	Sell	10,025 -5,500	-35%	-$71.7K	0.01%	409
2022 Q2	$195K	Hold	15,525	–	–	0.01%	412
2022 Q1	$168K	Buy	15,525 +25	+0.2%	+$304	0.01%	442
2021 Q4	$218K	Buy	15,500 +3,000	+24%	+$49.4K	0.01%	434
2021 Q3	$240K	Hold	12,500	–	–	0.01%	410
2021 Q2	$123K	Buy	+12,500	New	+$114K	0.01%	448
2020 Q1	–	Sell	-14,500	Closed	-$83K	–	412
2019 Q4	$83K	Hold	14,500	–	–	﹤0.01%	389
2019 Q3	$52K	Buy	+14,500	New	+$56.2K	﹤0.01%	413

Other funds holding DVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ingalls & Snyder LLC's DVAX Position: Q2 2024 in Review

Ingalls & Snyder LLC sold out of Dynavax Technologies (DVAX) in Q2 2024, closing a stake of 10,000 shares — an estimated $124K sold.

Ingalls & Snyder LLC first reported a position in DVAX in Q3 2019 and held it in 14 quarters. The position peaked at $240K in Q3 2021. 238 funds tracked by Wall St. Rank hold DVAX as of Q2 2024.

Ingalls & Snyder LLC reported no remaining Dynavax Technologies position as of Q2 2024 after selling out during the quarter.
Ingalls & Snyder LLC sold 10,000 Dynavax Technologies shares in Q2 2024, an estimated $124K.
Ingalls & Snyder LLC first reported a position in Dynavax Technologies in Q3 2019 and held it in 14 quarters.
Ingalls & Snyder LLC's Dynavax Technologies position peaked at $240K in Q3 2021.
238 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2024.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2024, filed 31 Jul 2024.